Eikon Therapeutics, Inc. (EIKN)
9.43
-0.17
(-1.77%)
USD |
NASDAQ |
Jun 03, 16:00
9.475
+0.04
(+0.48%)
After-Hours: 19:59
Eikon Therapeutics EPS Diluted (Quarterly) : -1.532 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| MacroGenics, Inc. | -0.5796 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Anika Therapeutics, Inc. | -0.3737 |
| Savara, Inc. | -0.1472 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -82.96M |
| Total Expenses (Quarterly) | 82.96M |
| Enterprise Value | 252.78M |
| Earnings Yield | -47.52% |